The onset of CVT can span from acute to subacute, and even chronic presentations, with
symptoms that are more varied than other stroke types and often nonspecific, which may …

The field of pediatric stroke has historically been hampered by limited evidence and small
patient cohorts. However the landscape of childhood stroke is rapidly changing due in part …

Direct oral anticoagulants (DOACs) provide an attractive alternative for the management and
prevention of thrombosis in pediatric patients. With multiple ongoing and published pediatric …

Venous thromboembolism (VTE) occurs in 2.1 to up to 50% of children with cancer and
contributes to long term morbidity as well as early mortality in this population. Pediatric …

Context Cerebral sinovenous thrombosis (CSVT) is a rare but life-threatening condition in
the pediatric population and there is no pediatric guidelines regarding anticoagulation for …

Venous thromboembolism is a major hospital acquired complication in the pediatric
population over the last two-decades, with a 130% increase in the past decade. Direct oral …

Objective Management of cerebral venous thrombosis (CVT) involves minimizing expansion
of the thrombus and promoting the recanalization of the venous sinus. While current …

This review used traditional and network meta-analyses (NMA) to conduct a comprehensive
study of antithrombotic therapies in children with thromboembolic disease. We searched the …

Introduction Paediatric clinical practice for treatment of venous thromboembolism (VTE) is
based on extrapolation from adult trials with minimal data on anticoagulation efficacy and …

Background We aimed to describe the clinical presentation, risk of bleeding and recurrent
thrombosis, and perioperative anticoagulant management of children with cerebral venous …